Emcure Pharmaceuticals share price jumped over 5% to hit a fresh 52-week high on Wednesday after domestic brokerage firm Kotak Institutional Equities initiated coverage on the stock with a bullish view. Kotak has assigned ‘Add’ rating to Emcure Pharmaceuticals shares with a target price of ₹1,655 per share, implying an upside potential of 11% from Tuesday’s closing price. Emcure Pharma …
